Sabrina Serani - Journalist Profile | Connect with top journalists

Beats

Biography

Content

Total articles 748

• Available on paid plans

  FDA Grants Novel Therapy RMAT Designation for Dysphagia Following Head and Neck Cancer Treatment

  By Sabrina Serani Verified

  Apr. 16, 2025

• Available on paid plans

  FDA Oks Sotorasib/Panitumumab in KRAS G12C-Mutant Colorectal Cancer

  By Sabrina Serani Verified, Jordyn Sava Verified

  Jan. 16, 2025

• Available on paid plans

  FDA Grants Novel Therapy RMAT Designation for Dysphagia Following Head and Neck Cancer Treatment

  By Sabrina Serani Verified

  Apr. 16, 2025

As seen in

Company Info

Targeted Oncology

Targeted Oncology is a key resource for oncology healthcare professionals, especially community oncologists. It provides valuable information on targeted therapies and immunotherapies in cancer treatment. As a brand under MJH Life Sciences, it is part of the largest privately held, independent medical media company in North America. The company offers a variety of services, including digital and print media that feature news and expert opinions on precision medicine in oncology. Targeted Oncology also hosts over 800 educational events each year, such as Case-Based Roundtable and Community Case Forum events, which facilitate networking and discussions among oncologists and hematologists. Additionally, it provides diverse content formats, including articles, videos, and podcasts, aimed at enhancing learning and practice outcomes in the field of oncology.